Activation receptor-induced tolerance of mature NK cells in vivo requires signaling through the receptor and is reversible

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 2765-2771

  Bolanos, Fred D ^a   Tripathy, Sandeep K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE KNOCK-IN TECHNIQUES; IMMUNE TOLERANCE; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUROMEGALOVIRUS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; RECEPTORS, IMMUNOLOGIC;

EID: 79952753924     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003046     Document Type: Article

References (40)

1. Bahram, S., H. Inoko, T. Shiina, and M. Radosavljevic. 2005. MIC and other NKG2D ligands: from none to too many. Curr. Opin. Immunol. 17: 505-509.
2. Fuchs, A., and M. Colonna. 2006. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin. Cancer Biol. 16: 359-366.
3. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, et al. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7: 517-523.
4. Arnon, T. I., H. Achdout, N. Lieberman, R. Gazit, T. Gonen-Gross, G. Katz, A. Bar-Ilan, N. Bloushtain, M. Lev, A. Joseph, et al. 2004. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103: 664-672. (Pubitemid 38140102)
5. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
6. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
7. Tripathy, S. K., H. R. Smith, E. A. Holroyd, J. T. Pingel, and W. M. Yokoyama. 2006. Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J. Virol. 80: 545-550.
8. Davis, A. H., N. V. Guseva, B. L. Ball, and J. W. Heusel. 2008. Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H. J. Immunol. 181: 265-275.
9. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
10. Mason, L. H., J. Willette-Brown, L. S. Taylor, and D. W. McVicar. 2006. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J. Immunol. 176: 6615-6623.
11. McVicar, D. W., and D. N. Burshtyn. 2001. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. Sci. STKE 2001: re1.
12. Coudert, J. D., L. Scarpellino, F. Gros, E. Vivier, and W. Held. 2008. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 111: 3571-3578.
13. Orr, M. T., J. C. Sun, D. G. Hesslein, H. Arase, J. H. Phillips, T. Takai, and L. L. Lanier. 2009. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J. Exp. Med. 206: 807-817.
14. Tassi, I., G. Le Friec, S. Gilfillan, T. Takai, W. M. Yokoyama, and M. Colonna. 2009. DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo. Eur. J. Immunol. 39: 1129-1135.
15. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
16. Cheng, T. P., A. R. French, B. F. Plougastel, J. T. Pingel, M. M. Orihuela, M. L. Buller, and W. M. Yokoyama. 2008. Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics 60: 565-573.
17. Dokun, A. O., S. Kim, H. R. Smith, H. S. Kang, D. T. Chu, andW. M. Yokoyama. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2: 951-956.
18. Tripathy, S. K., P. A. Keyel, L. Yang, J. T. Pingel, T. P. Cheng, A. Schneeberger, and W. M. Yokoyama. 2008. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 205: 1829-1841.
19. Sun, J. C., and L. L. Lanier. 2008. Tolerance of NK cells encountering their viral ligand during development. J. Exp. Med. 205: 1819-1828.
20. Coudert, J. D., J. Zimmer, E. Tomasello, M. Cebecauer, M. Colonna, E. Vivier, and W. Held. 2005. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 106: 1711-1717. (Pubitemid 41208585)
21. Wiemann, K., H. W. Mittrücker, U. Feger, S. A. Welte, W. M. Yokoyama, T. Spies, H. G. Rammensee, and A. Steinle. 2005. Systemic NKG2D downregulation impairs NK and CD8 T cell responses in vivo. J. Immunol. 175: 720-729. (Pubitemid 41094952)
22. Oppenheim, D. E., S. J. Roberts, S. L. Clarke, R. Filler, J. M. Lewis, R. E. Tigelaar, M. Girardi, and A. C. Hayday. 2005. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 6: 928-937.
23. Tomasello, E., P. O. Desmoulins, K. Chemin, S. Guia, H. Cremer, J. Ortaldo, P. Love, D. Kaiserlian, and E. Vivier. 2000. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13: 355-364.
24. Gilfillan, S., E. L. Ho, M. Cella, W. M. Yokoyama, and M. Colonna. 2002. NKG2D recruits two distinct adapters to trigger NK cell activation and co-stimulation. Nat. Immunol. 3: 1150-1155.
25. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
26. Takaki, R., S. R. Watson, and L. L. Lanier. 2006. DAP12: an adapter protein with dual functionality. Immunol. Rev. 214: 118-129.
27. Elliott, J. M., J. A. Wahle, and W. M. Yokoyama. 2010. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J. Exp. Med. 207: 2073-2079.
28. Joncker, N. T., N. Shifrin, F. Delebecque, and D. H. Raulet. 2010. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J. Exp. Med. 207: 2065-2072.
29. Cooper, M. A., J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero, and W. M. Yokoyama. 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 106: 1915-1919.
30. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
31. dull phenotype induction. Blood 109: 323-330.
32. De Maria, A., M. Fogli, P. Costa, G. Murdaca, F. Puppo, D. Mavilio, A. Moretta, and L. Moretta. 2003. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33: 2410-2418. (Pubitemid 37138973)
33. De Maria, A., and L. Moretta. 2008. NK cell function in HIV-1 infection. Curr. HIV Res. 6: 433-440.
34. Fauriat, C., M. A. Ivarsson, H. G. Ljunggren, K. J. Malmberg, and J. Michaëlsson. 2010. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115: 1166-1174.
35. Diefenbach, A., E. R. Jensen, A. M. Jamieson, and D. H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413: 165-171.
36. Diefenbach, A., A. M. Jamieson, S. D. Liu, N. Shastri, and D. H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1: 119-126.
37. Cerwenka, A., A. B. Bakker, T. McClanahan, J. Wagner, J. Wu, J. H. Phillips, and L. L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721-727.
38. Coudert, J. D., and W. Held. 2006. The role of the NKG2D receptor for tumor immunity. Semin. Cancer Biol. 16: 333-343.
39. Le Maux Chansac, B., A. Moretta, I. Vergnon, P. Opolon, Y. Lécluse, D. Grunenwald, M. Kubin, J. C. Soria, S. Chouaib, and F. Mami-Chouaib. 2005. NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J. Immunol. 175: 5790-5798. (Pubitemid 41508063)
40. Champsaur, M., J. N. Beilke, K. Ogasawara, U. H. Koszinowski, S. Jonjic, and L. L. Lanier. 2010. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J. Immunol. 185: 157-165.